| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/22/2009 | CN101412693A 4-[1-hydroxy-1-(2,3-dimethoxyphenyl)methyl]piperidine and method for preparing corresponding piperidine thereby |
| 04/21/2009 | US7521527 Glucagon-like peptide-1 (GLP-1); for treatment of diabetes, obesity, excessive appetite, insufficient satiety, and metabolic disorders; for converting liver stem/progenitor cells into functional pancreatic cells |
| 04/21/2009 | US7521447 2-aza-[4.3.0]bicyclic heteroaromatic rings; useful for the treatment of inflammation, osteoarthritis, rheumatoid arthritis, psoriasis, Crohn's disease, inflammatory bowel disease, cancer, autoimmune diseases, and for the treatment of other cytokine-mediated diseases |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521067 Compressing the first, second and third layers into a capsule-shaped osmotic tablet; by including an appropriate color scheme in multi-layer osmotic tablets, detection of formulation orientation is achieved by detecting the color at a spot location on a side of the tablet corresponding to one or another |
| 04/21/2009 | US7521062 Thiosemicarbazones as anti-virals and immunopotentiators |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/16/2009 | WO2007081396A3 Initiators and crosslinkable polymeric materials |
| 04/16/2009 | WO2005055934A3 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 04/16/2009 | WO2005016237A3 Methionine aminopeptidase and methods of use |
| 04/16/2009 | WO2004091524A3 Respiratory virus vaccines |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090099104 Substituted indazoles-o- glucosides |
| 04/16/2009 | US20090098120 Compositions and methods for the treatment of immune related diseases |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP1689353A4 Recovery of phytonutrients from oils |
| 04/15/2009 | EP1592392A4 Production of very long chain polyunsaturated fatty acids in oilseed plants |
| 04/15/2009 | EP1534122A4 Medical decision support systems utilizing gene expression and clinical information and method for use |
| 04/15/2009 | EP1458677B1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 04/15/2009 | EP1024805B1 Use of coumarin derivatives for the treatment of liver and pancreatic disorders |
| 04/15/2009 | CN101410130A Novel immunomodulating peptide |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101406469A Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406453A Pharmaceutical compositions for oral and topical administration |
| 04/15/2009 | CN100478027C Catheter composition and uses thereof for preparing medicine |
| 04/14/2009 | US7517853 Biodrugs for treatment of neoplasia and acromegaly |
| 04/14/2009 | US7517532 Dihydroxypyridopyrazine-1,6-dione compounds useful as HIV integrase inhibitors |
| 04/14/2009 | US7517531 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4 |
| 04/14/2009 | US7517269 Building element for constructing a modular substructure |
| 04/14/2009 | CA2192941C Sterol derivatives used for regulation of meiosis |
| 04/14/2009 | CA2170479C Benzothiophene compounds, intermediates, compositions, and methods |
| 04/09/2009 | WO2005055942A3 Modulation of brain pathways and function |
| 04/09/2009 | WO2005051309A3 Systems and methods for measuring tear film osmolarity |
| 04/09/2009 | WO2005041865A3 Compounds and method for treating cancer |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | WO2005027840A3 Combination approaches for generating immune responses |
| 04/09/2009 | WO2005025513A3 Guanidinium derivatives for improved cellular transport |
| 04/09/2009 | WO2005007090A3 Inhibitors of the map kinase pathway |
| 04/09/2009 | WO2004112728A3 Methods and agents for treating axonal damage, inhibition of neurotransmitter release and pain transmission, and blocking calcium influx in neurons |
| 04/09/2009 | WO2004110360A3 Proteoglycan degrading mutants for treatment of cns |
| 04/09/2009 | WO2004103287A3 B-arrestin-2 modulation in the treatment of allergic asthma |
| 04/09/2009 | WO2004100895A3 Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disorders |
| 04/09/2009 | WO2004084811A3 Crystals and structures of epidermal growth factor receptor kinase domain |
| 04/09/2009 | WO2003096976A3 Microcrystalline cewllulose compositions |
| 04/09/2009 | US20090093626 High Viscosity Xanthan Polymer Preparations |
| 04/09/2009 | US20090093401 Administering Cycstatin C homologues to inhibit transforming growth factor-beta stimulation of epithelial-mesenchymal transitions (EMT); antineoplastic agents |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2044948A1 Methods and compositions concerning poxviruses and cancer |
| 04/08/2009 | EP2044941A1 Multiple-phase formulation of drospirenone and estradiol as a contraceptive |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | CN101404892A Microcrystalline cewllulose compositions |
| 04/08/2009 | CN101402601A Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/08/2009 | CN101402562A Novel benzophenone derivatives or salts thereof |
| 04/08/2009 | CN100475953C Pancreatic stem cells |
| 04/08/2009 | CN100475233C Combination of Chinese traditional medicine for treating angina pectoris as well as preparation method and usage |
| 04/07/2009 | US7514555 Compounds for the treatment of metabolic disorders |
| 04/07/2009 | US7514534 comprising heavy chain and light chain immunoglobulin variable domain sequences; (complementary determining regions) CDR/antibodies, used to treat or prevent metastasis, hyperproliferation, inflammation and disorders characterized by excessive extracellular matrix degradation; enzyme inhibitors |
| 04/07/2009 | US7514467 Novel polymorphic form IV and solvate; precipitation from ethyl acetate |
| 04/07/2009 | US7514456 Nicotinamide derivatives useful as p38 inhibitors |
| 04/07/2009 | US7514420 Steroids having 1,8-unsaturation and formulations comprising same |
| 04/07/2009 | US7514419 Phosphorus-containing thyromimetics |
| 04/07/2009 | US7514086 Peptide-based vaccine for influenza |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | CA2362833C Phenylalaninol derivatives |
| 04/07/2009 | CA2312856C Use of ginkgo biloba extracts for preparing a medicine |
| 04/02/2009 | WO2005011569A3 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 04/02/2009 | WO2004110353A3 Novel immunomodulating peptide |
| 04/02/2009 | WO2004103262A3 Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells |
| 04/02/2009 | WO2004096156A3 Toll-like receptor 9 effector agents and uses thereof |
| 04/02/2009 | WO2004069199A3 Marketing system for improving patient compliance and methods and devices relating to same |
| 04/02/2009 | US20090088568 Vinorelbine derivatives |
| 04/02/2009 | US20090088482 Compositions and Methods For Treating Heart Failure |
| 04/02/2009 | US20090088407 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/02/2009 | US20090088382 Use of the cathelicidin LL-37 and derivatives therof for wound healing |
| 04/02/2009 | US20090087448 Stable Immunoprophylactic and Therapeutic Compositions Derived From Transgenic Plant Cells and Methods for Production |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/01/2009 | EP2042490A2 Benzimidazole derivatives as vanilloid receptor antagonists |
| 04/01/2009 | EP1638960A4 Preparation of chemical compounds |
| 04/01/2009 | EP1620429B1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 04/01/2009 | CN101397335A Particles of HCV envelope proteins: use for vaccination |
| 04/01/2009 | CN100473664C Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 03/31/2009 | US7511021 2-{3-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-6-methyl-1H-indazol-4-yloxy} beta-D-glucopyranoside; sodium glucose transporter inhibitor; antidiabetic agent; Syndrome X, obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, hypertension, ischemia, stroke, heart disease , and cataracts |
| 03/31/2009 | US7510835 Methods for identifying risk of breast cancer and treatments thereof |
| 03/31/2009 | US7510727 Unit dose sustained-release oral dosage form of melt extruded particles of specified particle size comprising a drug such as an opiod, one or more retardants, and an optional water insoluble binder |
| 03/31/2009 | US7510698 Adjuvant formulation consisting essentially of a metabolizable oil and alpha tocopherol in emulsion for enhancing immune response to infection |
| 03/31/2009 | US7510556 Vessel sealing instrument |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2349268C A process for the preparation of suspensions of drug particles for inhalation delivery |
| 03/26/2009 | WO2005002521A3 Methods for the identification of inhibitors of acetolactate synthase and potassium transport protein as antibiotics |
| 03/26/2009 | WO2004080387A3 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 03/26/2009 | US20090081676 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms |
| 03/26/2009 | US20090081286 Extended release venlafaxine formulation |
| 03/26/2009 | US20090081210 Methods of Killing Tumor Cells by Targeting Internal Antigens Exposed on Apoptotic Tumor Cells |
| 03/26/2009 | US20090081160 Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject |
| 03/25/2009 | EP2039761A1 Influenza vaccine composition |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039358A1 Pharmaceutical compositions comprising a macrolide and an acid |
| 03/25/2009 | EP1694325A4 Method of preventing survival of retrovirally cells and of inhibiting formation of infectious retroviruses |
| 03/25/2009 | EP1635641B1 Mitotic kinesin inhibitors |